Elevated serum C-reactive protein associates with deterioration of renal function in transplant recipients

Clinical Nephrology

Volumn 60, Issue 4, 2003, Pages 248-256

  Teppo, A M ^a,b   Tornroth T ^a   Honkanen, E ^a   Gronhagen Riska C ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b BIOMEDICUM HELSINKI   (Finland)

Author keywords

Graft inflammation; Renal allograft dysfunction; Serum C reactive protein (CRP)

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; ATROPHY; CHRONIC DISEASE; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE CLEARANCE; DETERIORATION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RECIPIENT; STATISTICAL ANALYSIS;

EID: 0141892586     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp60248     Document Type: Article

References (41)

1. Barnas U, Schmidt A, Haas M, Kaider A, Tillawi S, Wamser P, Mayer G 1997 Parameters associated with chronic renal transplant failure. Nephrol Dial Transplant 12 (Suppl 2): 82-85
2. Bautista LE, Lopez-Jaramillo P 2001 Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19: 857-861
3. Blake GJ, Ridger PM 2001 Novel clinical markers of vascular wall inflammation. Circ Res 89: 763-771
4. Blake GJ, Ridker PM 2002 Tumour necrosis factor-α, inflammatory biomarkers and atherogenesis. Eur Heart J 23: 345-347
5. Brazy PC, Pirch JD, Belzer FO 1992 Factors affecting renal allograft function in long-term recipients. Am J Kidney Dis 19: 558-566
6. Colhoun HM, Schalkwijk C, Ruhens MB, Stehouwer CDA 2002 C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care 25: 1813-1817
7. Cosio FG, Pesavento TE, Pelletier RP, Henry M, Ferguson RM, Kim S, Lemeshow S 2002 Patient survival after renal transplantation III: the effects of statins. Am J Kidney Dis 40: 638-643
8. Danesh J, Whincup P, Walker M, Lennon L, Thompson A, Appleby P, Gallimore JR, Pepys MB 2000 Low-grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 321: 199-204
9. deFerranti S, Rifai S 2002 C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta 317: 1-15
10. Dimeny E, Fellström B 1997 Metabolic abnormalities in renal transplant recipients. Risk factors and predictors of chronic graft dysfunction? Nephrol Dial Transplant 12: 21-24
11. Ekstrand A, Grönhagen-Riska C, Groop L, Kuhlbäck B, Ahonen J 1987 Outcome of patients with diabetic nephropathy after kidney transplantation. Acta Med Scand 222: 251-260
12. Fink JC, Onuigbo MA, Blahut SA, Christenson RH, Mann D, Bartlett ST, Weir MR 2002 Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study. Am J Kidney Dis 39: 1096-1101
13. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, Pepys MB 1999 C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 190: 1733-1739
14. Häyry P 1999 Chronic rejection: new potential venues of therapy. Transplant Proc 31: 1799-1800
15. Kasiske BL, Klinger D 2000 Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 11: 753-759
16. Lagrand WK, Niessen HWM, Wolbink G-J, Jaspars LH, Visser CA, Freek WA, Verheugt FWA, Meijer CJLM, Hack CE 1997 C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95: 97-103
17. Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt FWA, Wolbink G-J, Hack CE 1999 C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 100: 96-102
18. Lalla MLT, Eklund B, Ahonen J 1988 The clinical significance of C-reactive protein after renal transplantation. Transplant Proc 20: 402-404
19. Leggat JE Jr, Ojo AO, Leichman AB, Port FK, Wolfe RA, Turenne MN, Held PJ 1997 Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes. Transplantation 63: 1268-1272
20. Mange KC, Cizman B, Joffe M, Feldman HI 2000 Arterial hypertension and renal allograft survival. JAMA 283: 633-638
21. Maseri A 1997 Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 336: 1014-1015
22. Massy Z, Guijarro C, Wiederkehr M, Ma J, Kasiske B 1996 Chronic renal allograft rejection. Immunologic and non-immunologic risk factors. Kidney Int 49: 518-524
23. McMillan DE 1989 Increased levels of acute-phase serum proteins in diabetes. Metabolism 38: 1042-1046
24. Monaco AP, Burke JF, Ferguson RM, Halloran PF, Kahan BD, Light JA, Matas AJ, Solez K 1999 Current thinking on renal allograft rejection: issues, concerns, and recommendations from a 1997 round-table discussion. Am J Kidney Dis 33: 150-160
25. Morrow DA, Ridker PM 2000 C-reactive protein, inflammation and coronary risk. Med Clin North Am 84: 149-161
26. Nadeau KC, Azuma H, Tilney NL 1995 Sequential cytokine expression in renal allografts in chronic rejection. Proc Natl Acad Sci USA 92: 1575-1578
27. Nakahara C, Kanemoto K, Saito N, Oyake Y, Kamoda T, Nagata M, Matsui A 2001 C-reactive protein frequently localizes in the kidney in glomerular diseases. Clin Nephrol 55: 365-370
28. Pasceri V, Willerson JT, Yeh ET 2000 Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165-2168
29. Pepys MB 2001 The renaissance of C reactive protein. Br Med J 322: 4-5
30. Ponticelli C 2000 Progression of renal damage in chronic rejection. Kidney Int 57 (Suppl 75): S62-S70
31. Racusen LC, Solez K, Colvin RB et al 1999 The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723
32. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E 1999 Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 100: 230-235
33. Rush D, Nickerson P, Gough J, McKenna R, Grimm P, Cheang M, Trpkov K, Solez K, Jeffery J 1998 Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 9: 2129-2134
34. Schalwijk CG, Poland DCW, vanDijk W, Kok A, Dräger AM, Doni A, van Hindsbergh VWM, Stehouwer CDA 1999 Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42: 351-357
35. Silkensen JR 2000 Long-term complications in renal transplantation. J Am Soc Nephrol 11: 582-588
36. Stehouwer CDA, Gall M-A, Twisk JWR, Knudsen E, Emeis JJ, Parving H-H 2002 Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Progressive, interrelated and independently associated with risk of death. Diabetes 51: 1157-1165
37. Stenvinkel P, Andersson P, Wang T, Lindholm B, Bergström J, Palmblad J, Heimburger O, Cederholm T 1999 Do ACE inhibitors suppress tumour factor-α production in advanced chronic renal failure? J Intern Med 246: 503-507
38. Stuveling EM, Hillege HL, Bakker SJL, Gans ROB, de Jong PE, de Zeeuw D 2003 C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63: 654-661
39. Torzewski J, Torzewski M, Bowyer DE, Fröhlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V 1998 C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18: 1386-1392
40. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB 1999 Elevated C-reactive protein levels in overweight and obese adults. JAMA 282: 2131-2135
41. Yeun JY, Levine RA, Mantadilok V, Kaysen GA 2000 C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476